Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDGL

Madrigal Pharmaceuticals Inc

May 29 • 04:00PM ET

497.27

-18.69 -3.62 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: BBIO VKTX BMRN EXEL INCY KRYS ALNY RARE REGN VRTX

| Held by: VTI VB IWM VBK XBI VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-12.80	Insider Own	8.66%	Shs Outstand	23.04M	Perf Week	-3.18%
Market Cap	11.46B	Forward P/E	47.18	EPS next Y	10.54	Insider Trans	-5.32%	Shs Float	21.06M	Perf Month	-4.11%
Enterprise Value	10.99B	PEG	-	EPS next Q	-2.38	Inst Own	105.18%	Short Float	18.51%	Perf Quarter	15.11%
Income	-309.44M	P/S	10.12	EPS this Y	49.05%	Inst Trans	2.78%	Short Ratio	12.42	Perf Half Y	-16.01%
Sales	1.13B	P/B	21.08	EPS next Y	260.99%	ROA	-27.83%	Short Interest	3.90M	Perf YTD	-14.61%
Book/sh	23.59	P/C	14.02	EPS next 5Y	-	ROE	-49.35%	52W High	615.00 -19.14%	Perf Year	84.22%
Cash/sh	35.48	P/FCF	-	EPS past 3/5Y	9.32% 0.37%	ROIC	-34.80%	52W Low	265.20 87.51%	Perf 3Y	74.55%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	92.94%	Volatility	3.54% 4.24%	Perf 5Y	342.80%
Dividend TTM	-	EV/Sales	9.71	EPS Y/Y TTM	29.06%	Oper. Margin	-27.68%	ATR (14)	20.85	Perf 10Y	3830.21%
Dividend Ex-Date	-	Quick Ratio	3.16	Sales Y/Y TTM	256.82%	Profit Margin	-27.32%	RSI (14)	42.50	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	3.50	EPS Q/Q	1.93%	SMA20	-3.93%	Beta	-1.06	Target Price	679.33
Payout	-	Debt/Eq	0.64	Sales Q/Q	126.84%	SMA50	-3.11%	Rel Volume	1.39	Prev Close	515.96
Employees	915	LT Debt/Eq	0.64	Earnings	May 06 BMO	SMA200	1.93%	Avg Volume	313.71K	Price	497.27
IPO	Feb 06, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.16% 3.42%	Trades		Volume	435,859	Change	-3.62%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)